IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
In 2020-21 echo, why Punjab BJP is in line of protesting farmers’ fire again
State BJP is facing fresh accusation for not reaching out to farm unions to facilitate talks with the Centre for resolving ...
Axsome to seek approval for Alzheimer's-related agitation drug despite mixed data
Axsome Therapeutics said on Monday it would seek marketing approval next year for its oral drug to treat agitation in patients with Alzheimer's disease, after it succeeded in three out of four ...
STAT9d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
MedCity News9d
Axsome Aims for FDA Filing in Alzheimer’s Agitation Despite Mixed Bag of Phase 3 Data
Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...
Axsome Therapeutics Remains A Buy Despite AXS-05's Mixed Results
Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.
Adv Vishnu Dhoble’s Book On Dalit Students' Scholarship Agitation Launched At Gandhi Bhavan
The senior counsel and Samajwadi Janparishad state president, Adv Vishnu Dhoble’s book ‘Shishvruti Vadhiche Sansadiya Andolan ...
Aurangabad: Lawyers Protest In Lekhni Bandh Agitation Against Charges On Two Members
The District Lawyers' Association staged a Lekhni Bandh agitation to condemn the charges framed against association members Adv Siddhar Kashinath Bansode and Adv Kishor Uttamrao Vaishnav at the Satara ...